Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

No significant between-group differences were observed in lipid profile, renal function, thyroid function, vitamin D status, inflammatory biomarkers, or most other laboratory parameters.

Source: 3.2. Biochemical Characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This single-center cross-sectional case: control study was conducted between 1 January 2024 and 31 December 2025.

Source: Methods.

Patients were considered eligible for the PHPT group when biochemical evaluation confirmed PHPT according to the predefined diagnostic criteria and all study inclusion and exclusion criteria were fulfilled.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Cardiovascular Alterations in Primary Hyperparathyroidism: Associations with Risk Profile, Cardiac Structure, and Function

Case-control study · Journal of Clinical Medicine · 2026

Original publication title

Cardiovascular Alterations in Primary Hyperparathyroidism: Associations with Risk Profile, Cardiac Structure, and Function

Desislava Zamfirova; Mihail Boyanov; Stefan Naydenov

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background/Objectives:

Primary hyperparathyroidism (PHPT) has been associated with cardiovascular abnormalities, but the extent to which these reflect PHPT or conventional risk factors remains uncertain. We compared cardiovascular risk profiles and cardiac findings in patients with PHPT and controls.

Methods:

In this single-center cross-sectional case: control study, 5868 hospitalized patients were screened between January 2024 and December 2025. Fifty-four patients with biochemically confirmed PHPT and 23 age: and sex-comparable controls underwent standardized clinical, laboratory, 12-lead electrocardiogram (ECG), 24-h Holter ECG, and transthoracic echocardiographic assessment.

Results:

Patients with PHPT had higher systolic blood pressure (132.5 vs. 130.0 mmHg; p = 0.049), more type 2 diabetes (18.5% vs. 0%; p = 0.028), left ventricular hypertrophy (57.4% vs. 30.4%; p = 0.046), longer transmitral flow deceleration time (281.5 vs. 222.0 ms; p < 0.001), higher pulmonary artery systolic pressure (PASP) (24.5 vs. 19.0 mmHg; p < 0.001), and more aortic valve sclerosis/fibrotic thickening (38.9% vs. 13.0%; p = 0.032). High/very high cardiovascular risk was present in 54/54 (100%) PHPT patients versus 20/23 (86.96%) controls (p = 0.024). After adjustment, PHPT remained associated with longer deceleration time, higher PASP, aortic valve sclerosis/fibrotic thickening, and pericardial effusion.

Conclusions:

PHPT was associated with selected echocardiographic abnormalities, but causality cannot be inferred. Larger prospective studies are needed.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background/Objectives

Primary hyperparathyroidism (PHPT) has been associated with cardiovascular abnormalities, but the extent to which these reflect PHPT or conventional risk factors remains uncertain. We compared cardiovascular risk profiles and cardiac findings in patients with PHPT and controls.

Source: Background/Objectives

Abstract: Results

Patients with PHPT had higher systolic blood pressure (132.5 vs. 130.0 mmHg; p = 0.049), more type 2 diabetes (18.5% vs. 0%; p = 0.028), left ventricular hypertrophy (57.4% vs. 30.4%; p = 0.046), longer transmitral flow deceleration time (281.5 vs. 222.0 ms; p < 0.001), higher pulmonary artery systolic pressure (PASP) (24.5 vs. 19.0 mmHg; p < 0.001), and more aortic valve sclerosis/fibrotic thickening (38.9% vs. 13.0%; p = 0.032). High/very high cardiovascular risk was present in 54/54 (100%) PHPT patients versus 20/23 (86.96%) controls (p = 0.024). After adjustment, PHPT remained associated with longer deceleration time, higher PASP, aortic valve sclerosis/fibrotic thickening, and pericardial effusion.

Source: Results

Abstract: Conclusions

PHPT was associated with selected echocardiographic abnormalities, but causality cannot be inferred. Larger prospective studies are needed.

Source: Conclusions
Authors’ abstract

Background/Objectives:

Primary hyperparathyroidism (PHPT) has been associated with cardiovascular abnormalities, but the extent to which these reflect PHPT or conventional risk factors remains uncertain. We compared cardiovascular risk profiles and cardiac findings in patients with PHPT and controls.

Methods:

In this single-center cross-sectional case: control study, 5868 hospitalized patients were screened between January 2024 and December 2025. Fifty-four patients with biochemically confirmed PHPT and 23 age: and sex-comparable controls underwent standardized clinical, laboratory, 12-lead electrocardiogram (ECG), 24-h Holter ECG, and transthoracic echocardiographic assessment.

Results:

Patients with PHPT had higher systolic blood pressure (132.5 vs. 130.0 mmHg; p = 0.049), more type 2 diabetes (18.5% vs. 0%; p = 0.028), left ventricular hypertrophy (57.4% vs. 30.4%; p = 0.046), longer transmitral flow deceleration time (281.5 vs. 222.0 ms; p < 0.001), higher pulmonary artery systolic pressure (PASP) (24.5 vs. 19.0 mmHg; p < 0.001), and more aortic valve sclerosis/fibrotic thickening (38.9% vs. 13.0%; p = 0.032). High/very high cardiovascular risk was present in 54/54 (100%) PHPT patients versus 20/23 (86.96%) controls (p = 0.024). After adjustment, PHPT remained associated with longer deceleration time, higher PASP, aortic valve sclerosis/fibrotic thickening, and pericardial effusion.

Conclusions:

PHPT was associated with selected echocardiographic abnormalities, but causality cannot be inferred. Larger prospective studies are needed.

Publication and source details

Original title: Cardiovascular Alterations in Primary Hyperparathyroidism: Associations with Risk Profile, Cardiac Structure, and Function

Desislava Zamfirova; Mihail Boyanov; Stefan Naydenov

Journal of Clinical Medicine · 2026

* Correspondence: snaydenov@gmail.com; Tel.: +359-888-52-84-17© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:49:17.638030+00:00

DOI: 10.3390/jcm15176605 · PMC13566182